News Chart Celularity Inc.

Equities

CELU

US1511902041

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
3 ^USD	-1.64%		+1.69%	+21.26%

03-26	Celularity Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L	CI
03-20	Celularity Seeks FDA Orphan Drug Status for PDA-002 in Facioscapulohumeral Muscular Dystrophy	MT

78a3c8458572f1e19cee1f6bf5e60.fLuBUHD1dNsPbdO0USOHFGjR1nG0q7PnNaf19LehMbo.UdTRCEiwLI52XoXQJ2_peiW3kwvc_eSrXu6XkcXPeMgE7swDIIQY6z4luA~46aabdfd20ca37da2ee6d55bea57a957